| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| arzoxifene | estrogen receptor alpha | small molecule | NA | drugbank , DGIDB | Endometrial Carcinoma[MeSHID:D016889] Malignant neoplasm of breast[MeSHID:D001943] Osteoporosis[MeSHID:D010024] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.32 | approved,investigational | unknown |
| arzoxifene | estrogen receptor | NA | Successful target | TTD , DGIDB | Endometrial Carcinoma[MeSHID:D016889] Malignant neoplasm of breast[MeSHID:D001943] Osteoporosis[MeSHID:D010024] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.32 | approved | unknown |
| arzoxifene | estrogen receptor beta | small molecule | Successful target | TTD , drugbank , DGIDB | Endometrial Carcinoma[MeSHID:D016889] Malignant neoplasm of breast[MeSHID:D001943] Osteoporosis[MeSHID:D010024] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.46 | approved,investigational | unknown |
| click here to return to the previous page | ||||||||